Results of a phase II study of single-agent sunitinib in elderly non-small cell lung cancer patients.
C. Reynolds
Consultant or Advisory Role - Pfizer
A. I. Spira
No relevant relationships to disclose
W. L. Gluck
No relevant relationships to disclose
R. E. Pluenneke
No relevant relationships to disclose
K. A. Boehm
No relevant relationships to disclose
F. Zhan
No relevant relationships to disclose
L. Asmar
No relevant relationships to disclose